10x Genomics, Inc. TXG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.11% | 11.20% | 85.57% | 76.16% | 58.19% |
| Total Depreciation and Amortization | 12.34% | 13.10% | -0.17% | -12.52% | -18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.52% | -15.28% | -21.31% | -19.34% | -21.64% |
| Change in Net Operating Assets | 158.66% | 473.95% | -94.57% | 1,888.76% | -74.69% |
| Cash from Operations | 12.63% | 89.82% | 125.27% | 1,941.57% | 126.00% |
| Capital Expenditure | 13.69% | 43.94% | 50.43% | 52.11% | 47.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 21.62% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.79% | 102.85% | 106.07% | 108.72% | -205.64% |
| Cash from Investing | 82.04% | 66.14% | 71.53% | 58.82% | -297.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 54.85% | -28.65% | -31.39% | -37.67% | -24.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.88% | -129.50% | -120.99% | -37.67% | -24.41% |
| Foreign Exchange rate Adjustments | -238.95% | -125.21% | 14,950.00% | 395.12% | -5.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 170.56% | 485.87% | 432.07% | 953.64% | -58.58% |